Paris-based digital health company Alan has secured new funding at a €5.5 billion valuation, with Prosus investing €400 million as part of a broader €480 million round.
The deal includes both primary and secondary equity. Existing backers Teachers' Venture Growth and Index Ventures also participated, alongside new investor Dara Holdings. The transaction remains subject to regulatory approvals, including from French financial authorities.
Founded by Jean-Charles Samuelian-Werve, Alan combines health insurance, digital care and preventive tools in a single app designed to simplify reimbursements, access to care and personalised prevention. The company said the new capital will be used to support international expansion and AI-led product development.
The round adds to investor interest in European healthtech companies applying AI to insurance and care delivery, as Alan expands beyond France and builds out its platform.
The deal includes both primary and secondary equity. Existing backers Teachers' Venture Growth and Index Ventures also participated, alongside new investor Dara Holdings. The transaction remains subject to regulatory approvals, including from French financial authorities.
Founded by Jean-Charles Samuelian-Werve, Alan combines health insurance, digital care and preventive tools in a single app designed to simplify reimbursements, access to care and personalised prevention. The company said the new capital will be used to support international expansion and AI-led product development.
The round adds to investor interest in European healthtech companies applying AI to insurance and care delivery, as Alan expands beyond France and builds out its platform.